An open label dose finding study of allopurinol to target defined reduction in urate levels in hemodialysis patients

Elaine Rutherford; Graham Stewart; J. Graeme Houston; Alan G. Jardine; Patrick B. Mark; Allan D. Struthers

doi:10.1002/jcph.939

An open label dose finding study of allopurinol to target defined reduction in urate levels in hemodialysis patients

Elaine Rutherford (Lead / Corresponding author), Graham Stewart, J. Graeme Houston, Alan G. Jardine, Patrick B. Mark, Allan D. Struthers

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)

200 Downloads (Pure)

Original language	English
Pages (from-to)	1409-1414
Number of pages	6
Journal	Journal of Clinical Pharmacology
Volume	57
Issue number	11
Early online date	9 Jun 2017
DOIs	https://doi.org/10.1002/jcph.939
Publication status	Published - 10 Oct 2017

Keywords

Allopurinol
Hemodialysis
Urate
Clinical trial
Dosing

Access to Document

10.1002/jcph.939Licence: CC BY

Final Published Version
Copyright 2017, The Authors. The Journal of Clinical Pharmacology Published by Wiley Periodicals, Inc . on behalf of American College of Clinical Pharmacology. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Final published version, 349 KBLicence: CC BY

Does Allopurinol Regress Left Ventricular Hypertrophy in End Stage Renal Disease (Joint with University of Glasgow)
Houston, G. (Investigator) & Struthers, A. (Investigator)
British Heart Foundation
1/04/13 → 31/07/16
Project: Research

Tayside Clinical Trials Unit
Health and Clinical Services
Facility/equipment: Facility

Cite this

@article{7e4625823c144e038b3e30f541dc88a3,

title = "An open label dose finding study of allopurinol to target defined reduction in urate levels in hemodialysis patients",

keywords = "Allopurinol, Hemodialysis, Urate, Clinical trial, Dosing",

author = "Elaine Rutherford and Graham Stewart and Houston, {J. Graeme} and Jardine, {Alan G.} and Mark, {Patrick B.} and Struthers, {Allan D.}",

note = "Funding: British Heart Foundation Project Grant (PG/12/72/29743).",

year = "2017",

month = oct,

day = "10",

doi = "10.1002/jcph.939",

language = "English",

volume = "57",

pages = "1409--1414",

journal = "Journal of Clinical Pharmacology",

issn = "0091-2700",

publisher = "Wiley",

number = "11",

}

TY - JOUR

T1 - An open label dose finding study of allopurinol to target defined reduction in urate levels in hemodialysis patients

AU - Rutherford, Elaine

AU - Stewart, Graham

AU - Houston, J. Graeme

AU - Jardine, Alan G.

AU - Mark, Patrick B.

AU - Struthers, Allan D.

N1 - Funding: British Heart Foundation Project Grant (PG/12/72/29743).

PY - 2017/10/10

Y1 - 2017/10/10

KW - Allopurinol

KW - Hemodialysis

KW - Urate

KW - Clinical trial

KW - Dosing

U2 - 10.1002/jcph.939

DO - 10.1002/jcph.939

M3 - Article

C2 - 28597919

SN - 0091-2700

VL - 57

SP - 1409

EP - 1414

JO - Journal of Clinical Pharmacology

JF - Journal of Clinical Pharmacology

IS - 11

ER -

An open label dose finding study of allopurinol to target defined reduction in urate levels in hemodialysis patients

Keywords

Access to Document

Projects

Does Allopurinol Regress Left Ventricular Hypertrophy in End Stage Renal Disease (Joint with University of Glasgow)

Equipment

Tayside Clinical Trials Unit

Cite this